Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
Clicks: 281
ID: 8029
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
71.3
/100
281 views
225 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy| Reference Key |
restelli2019costeffectivenessinfection
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Umberto Restelli;Davide Croce;Valeria Pacelli;Fabio Ciceri;Corrado Girmenia; |
| Journal | Infection and drug resistance |
| Year | 2019 |
| DOI | 10.2147/IDR.S196282 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.